JENNIFER WILCOX: Open Payments
NPI 1134438567 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,501 in 116 payments from 30 companies in 2025. Trend: 2023 $324 · 2024 $6,369 · 2025 $2,501
Food & beverage: $2,501
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $188 |
| GlaxoSmithKline, LLC. | 14 | $172 |
| AstraZeneca Pharmaceuticals LP | 9 | $162 |
| Exact Sciences Corporation | 8 | $156 |
| Sumitomo Pharma America, Inc. | 7 | $153 |
| Viatris Specialty LLC | 6 | $148 |
| Novo Nordisk Inc | 8 | $137 |
| PFIZER INC. | 6 | $128 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
Products named: TRELEGY ELLIPTA, GEMTESA, YUPELRI, DUPIXENT, Cologuard Collection Kit, FARXIGA, CAPLYTA, REXULTI.
Industry payments across NY — which companies pay providers there.
